3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and dithiothreitol

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with dithiothreitol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eshak, M; Iannotti, F; Pringle, AK; Self, J1
Fan, XL; Huang, XD; Li, ZH; Tong, WW1

Other Studies

2 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and dithiothreitol

ArticleYear
Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
    The European journal of neuroscience, 2000, Volume: 12, Issue:11

    Topics: 2-Amino-5-phosphonovalerate; Animals; Dithionitrobenzoic Acid; Dithiothreitol; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hippocampus; Ischemic Attack, Transient; Memantine; N-Methylaspartate; Neurons; Neuroprotective Agents; Organ Culture Techniques; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate

2000
Application of HPLC-ESI-ITMS in the quality control of carboxyterminal sequence confirmation for the recombinant DNA product Hirudin Variant 3.
    Journal of pharmaceutical and biomedical analysis, 2007, Jan-17, Volume: 43, Issue:2

    Topics: Alkylating Agents; Alkylation; Amino Acid Sequence; Carboxypeptidases; Cathepsin A; Chromatography, High Pressure Liquid; Dithiothreitol; Hirudins; Iodoacetamide; Molecular Sequence Data; Molecular Weight; Peptide Mapping; Quality Control; Recombinant Proteins; Reducing Agents; Reproducibility of Results; Sequence Analysis, Protein; Spectrometry, Mass, Electrospray Ionization; Technology, Pharmaceutical; Time Factors

2007